UM22-2 Human Pluripotent Stem Cells
Catalog Number: PLX02 001 R01
Cell number per vial: 1 million, 25 million, or 100 million
Pluristyx Ready-to-Differentiate (RTD™) UM22-2 cells are cryopreserved at 1, 25, or 100 million cells per vial with a >80% viable cell recovery when handled and thawed following the instructions for use.
Format: Research Use Only; not for diagnostic or therapeutic purposes
Passage number: pending
NIH Registration Number: 0209
NIH Approval Number: NIHhESC-13-0209
Pluripotency Markers: OCT4 & SSEA-4 (>90%); SSEA-1 (<10%)OCT4 & SSEA-4 (>90%); SSEA-1 (<10%)
UM22-2 hPSC conform to Global Ethical Standards and Clinical Cell Regulations with complete donor history and testing information. UM22-2 are registered with the National Institutes of Health (NIHhESC-13-0209). Pluristyx is a licensed manufacturer and distributor of human pluripotent stem cells obtained the University of Michigan
Cell Bank Manufacturing
Pluristyx hPSC cell bank vials are tested and confirmed to be free of adventitious agents, including mycoplasma, bacteria, yeast, fungi, and human virus. The cells have been characterized with regards to karyotype, pluripotency, and have been Short Tandem Repeat (STR) fingerprinted to confirm cell line identity.
These cells are for Research Use Only (RUO) and shall not be developed for diagnostic, therapeutic, or commercial use.
UM22-2 R&D Vial
Herron, TJ and Smith, GD et al; J Mol Cell Cardiol 2016 October; 99: 197-206